![]() |
|
|
Vol. 287, Issue 2, 667-671, November 1998
Department of Physiology, Uppsala University, Uppsala, Sweden
(J.P.K., R.S., K.E.O.A.) and
Department of Biochemistry and Pharmacy,
Åbo Akademi University, Turku, Finland (J.P.K., A.R.)
The agonist profiles for Ca++ elevations mediated by the
human alpha-2 adrenoceptor subtypes alpha-2A,
alpha-2B and alpha-2C were compared in the clones
of Chinese hamster ovary cells expressing comparable numbers of
receptors. No difference was seen between the different clones with
respect to the maximum Ca++ mobilizations or the
concentrations producing half-maximal stimulation in response to
noradrenaline. Ca++ elevations were sensitive to
phospholipase C inhibitor U-73122 (1-[6-([17
]-3-methoxyestra-1,3,5[10]-trien-17-yl)aminohexyl]-1H-pyrrole-2,5-dione) and pertussis toxin-pretreatment. Although noradrenaline was equally potent and active in all the clones, marked differences in the response
to the other agonists were seen. UK14,304
(5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine) was a
full agonist (when compared to noradrenaline) for alpha-2A and alpha-2C, D-medetomidine
([+]-[S]-[4-(1-[2,3-dimethylphenyl]ethyl)-1H-imidazole]HCl) was
a full agonist for alpha-2B and alpha-2C and
oxymetazoline (3-[(4,5-dihydro-1H-imidazol-2-yl-)methyl]-6-[1,1-dimethylethyl]-2,4-dimethylphenol HCl) was a full agonist only for alpha-2B receptors.
Clonidine (2-[2,6-dichloroaniline]-2-imidazoline HCl) was a partial
agonist in all the cases; almost no response to this ligand was
obtained in the alpha-2B-expressing cells. When the
Ca++ responses are compared to the previously published
results on cAMP inhibition in Chinese hamster ovary cells, clonidine
seems to be significantly less efficacious in elevating
Ca++ than in decreasing cAMP.
This article has been cited by other articles:
![]() |
S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Chotani, S. Flavahan, S. Mitra, D. Daunt, and N. A. Flavahan Silent alpha 2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1075 - H1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pauwels, S. Tardif, T. Wurch, and F. C. Colpaert Facilitation of Constitutive alpha 2A-Adrenoceptor Activity by Both Single Amino Acid Mutation (Thr373Lys) and Galpha o Protein Coexpression: Evidence for Inverse Agonism J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 654 - 663. [Abstract] [Full Text] |
||||
![]() |
E. A. Jewell-Motz, K. M. Small, C. T. Theiss, and S. B. Liggett alpha 2A/alpha 2C-Adrenergic Receptor Third Loop Chimera Show That Agonist Interaction with Receptor Subtype Backbone Establishes G Protein-coupled Receptor Kinase Phosphorylation J. Biol. Chem., September 8, 2000; 275(37): 28989 - 28993. [Abstract] [Full Text] [PDF] |
||||